These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38193154)

  • 21. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
    Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
    Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of breast mass morphology with diffusion-weighted MRI: Beyond apparent diffusion coefficient.
    Kul S; Metin Y; Kul M; Metin N; Eyuboglu I; Ozdemir O
    J Magn Reson Imaging; 2018 Dec; 48(6):1668-1677. PubMed ID: 29734493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value.
    Partridge SC; DeMartini WB; Kurland BF; Eby PR; White SW; Lehman CD
    AJR Am J Roentgenol; 2009 Dec; 193(6):1716-22. PubMed ID: 19933670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of orbital masses by multiparametric MRI.
    Ro SR; Asbach P; Siebert E; Bertelmann E; Hamm B; Erb-Eigner K
    Eur J Radiol; 2016 Feb; 85(2):324-36. PubMed ID: 26781137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI.
    Ohashi A; Kataoka M; Iima M; Kanao S; Honda M; Urushibata Y; Nickel MD; Kishimoto AO; Ota R; Toi M; Togashi K
    Magn Reson Imaging; 2020 Sep; 71():154-160. PubMed ID: 32302738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI.
    Malek M; Pourashraf M; Mousavi AS; Rahmani M; Ahmadinejad N; Alipour A; Hashemi FS; Shakiba M
    Asian Pac J Cancer Prev; 2015; 16(8):3407-12. PubMed ID: 25921153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images.
    Kanao S; Kataoka M; Iima M; Ikeda DM; Toi M; Togashi K
    Magn Reson Imaging; 2018 Jul; 50():38-44. PubMed ID: 29545213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis.
    Kul S; Metin Y; Bekircavusoglu S; Kul M
    Clin Imaging; 2021 Sep; 77():17-24. PubMed ID: 33639496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast MRI in the era of diffusion weighted imaging: do we still need signal-intensity time curves?
    Dietzel M; Ellmann S; Schulz-Wendtland R; Clauser P; Wenkel E; Uder M; Baltzer PAT
    Eur Radiol; 2020 Jan; 30(1):47-56. PubMed ID: 31359125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors.
    Kul S; Cansu A; Alhan E; Dinc H; Gunes G; Reis A
    AJR Am J Roentgenol; 2011 Jan; 196(1):210-7. PubMed ID: 21178069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps.
    Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
    Clin Radiol; 2018 May; 73(5):460-466. PubMed ID: 29295753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of combined diffusion-weighted imaging with dynamic contrast enhancement MRI in differentiating malignant from benign bone lesions.
    Cao J; Xiao L; He B; Zhang G; Dong J; Wu Y; Xie H; Wang G; Lin X
    Clin Radiol; 2017 Sep; 72(9):793.e1-793.e9. PubMed ID: 28545685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors.
    Marino MA; Avendano D; Sevilimedu V; Thakur S; Martinez D; Lo Gullo R; Horvat JV; Helbich TH; Baltzer PAT; Pinker K
    Eur J Radiol; 2022 Nov; 156():110523. PubMed ID: 36122521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
    Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
    Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL; Rahmat K; Rozalli FI; Mohd-Shah MN; Aziz YF; Yip CH; Vijayananthan A; Ng KH
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
    Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
    Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additional value of diffusion-weighted imaging to evaluate multifocal and multicentric breast cancer detected using pre-operative breast MRI.
    Song SE; Park EK; Cho KR; Seo BK; Woo OH; Jung SP; Cho SB
    Eur Radiol; 2017 Nov; 27(11):4819-4827. PubMed ID: 28593433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.